The cannabis withdrawal syndrome.
paper
Cited
Public
Unavailable
- Authors
- Budney, Alan J; Hughes, John R
- Year
- 2006
- Journal
- Current opinion in psychiatry
- PMID
- 16612207
- DOI
- 10.1097/01.yco.0000218592.00689.e5
PURPOSE OF REVIEW: The demand for treatment for cannabis dependence has grown dramatically. The majority of the people who enter the treatment have difficulty in achieving and maintaining abstinence from cannabis. Understanding the impact of cannabis withdrawal syndrome on quit attempts is of obvious importance. Cannabis, however, has long been considered a 'soft' drug, and many continue to question whether one can truly become dependent on cannabis. Skepticism is typically focused on whether cannabis use can result in 'physiological' dependence or withdrawal, and whether withdrawal is of clinical importance. RECENT FINDINGS: The neurobiological basis for cannabis withdrawal has been established via discovery of an endogenous cannabinoid system, identification of cannabinoid receptors, and demonstrations of precipitated withdrawal with cannabinoid receptor antagonists. Laboratory studies have established the reliability, validity, and time course of a cannabis withdrawal syndrome and have begun to explore the effect of various medications on such withdrawal. Reports from clinical samples indicate that the syndrome is common among treatment seekers. SUMMARY: A clinically important withdrawal syndrome associated with cannabis dependence has been established. Additional research must determine how cannabis withdrawal affects cessation attempts and the best way to treat its symptoms.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Gender differences in circumstances associated with cannabis use. | Martin EL et al. | โ | 2025 | โ |
| Impact of nicotine, cannabis, co-use and non-use on single day morning and evening cortisol and subjective state: During ambulatory assessment. | Keogh TM et al. | โ | 2025 | โ |
| Synthetic Cannabinoid Withdrawal: A Systematic Review of Case Reports. | Sharma R et al. | โ | 2025 | โ |
| A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects. | Ferretti ML et al. | โ | 2024 | โ |
| Cannabinoid Hyperemesis Syndrome (CHS) - An emerging gastrointestinal disorder and clinical challenge. | McFee RB | โ | 2024 | โ |
| Decomposing the late positive potential to cannabis cues in regular cannabis users: A temporal-spatial principal component analysis. | Preston TJ et al. | โ | 2024 | โ |
| Differential disruption of response alternation by precipitated ฮ<sup>9</sup>-THC withdrawal and subsequent ฮ<sup>9</sup>-THC abstinence in mice. | Eckard ML et al. | โ | 2024 | โ |
| Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options. | Corley C et al. | โ | 2024 | โ |
| "Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression. | Bortolato M et al. | โ | 2024 | โ |
| Cannabis use for medical symptoms: Patterns over the first year of use. | Gilman JM et al. | โ | 2023 | โ |
| Role of neuronal nicotinic acetylcholine receptors in cannabinoid dependence. | Buzzi B et al. | โ | 2023 | โ |
| Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. | Martin EL et al. | โ | 2023 | โ |
| Sleep disturbance after cessation of cannabis administration inย mice. | Asano T et al. | โ | 2023 | โ |
| The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review. | Towobola A et al. | โ | 2023 | โ |
| Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults. | Sullivan RM et al. | โ | 2022 | โ |
| Cannabinoids in the Orthopedic Setting: A Literature Review. | Carreira DS et al. | โ | 2022 | โ |
| Cannabis dosing and administration for sleep: a systematic review. | Velzeboer R et al. | โ | 2022 | โ |
| Clinical management of cannabis withdrawal. | Connor JP et al. | โ | 2022 | โ |
| Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques. | Kohut SJ et al. | โ | 2022 | โ |
| Evidence for spontaneous cannabinoid withdrawal in mice. | Paronis C et al. | โ | 2022 | โ |
| Investigating associations between appetite-regulating hormones, aggression and craving in males with cannabis use disorder. | Kurt Tunagur EM et al. | โ | 2022 | โ |
| Using Decision Trees to Identify Salient Predictors of Cannabis-Related Outcomes. | Schwebel FJ et al. | โ | 2022 | โ |
| A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction. | Peters KZ et al. | โ | 2021 | โ |
| Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22. | Hur KH et al. | โ | 2021 | โ |
| Assessing Aerobic Fitness Level in Relation to Affective and Behavioral Functioning in Emerging Adult Cannabis Users. | Wade NE et al. | โ | 2021 | โ |
| Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents. | Cooke ME et al. | โ | 2021 | โ |
| Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings. | Kesner AJ et al. | โ | 2021 | โ |
| CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions. | Covelo A et al. | โ | 2021 | โ |
| Dexmedetomidine for Treatment of Delayed Peak Symptoms of Cannabis Withdrawal Syndrome: A Case Report. | MacCamy K et al. | โ | 2021 | โ |
| Erratum To: Implementation of a Blind Quality Control Program in Blood Alcohol Analysis. | Moral J et al. | โ | 2021 | โ |
| Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey. | Armour M et al. | โ | 2021 | โ |
| Implementation of Mathematical Models to Predict New Cannabis Use by Urine Drug Testing: It Is Time to Move Forward. | Breindahl T et al. | โ | 2021 | โ |
| Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility. | Kichloo A et al. | โ | 2021 | โ |
| Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. | Bahji A et al. | โ | 2021 | โ |
| Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain. | Coughlin LN et al. | โ | 2021 | โ |
| Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders. | Navarrete F et al. | โ | 2021 | โ |
| Teaching Residents to Treat Substance Use Disorders: Overcoming 10 Common Patient-Perceived Barriers to Outpatient Treatment Engagement. | Davidson SM et al. | โ | 2021 | โ |
| Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates. | Kangas BD et al. | โ | 2020 | โ |
| Care of the Patient Using Cannabis. | Williams AR et al. | โ | 2020 | โ |
| Dopamine and Addiction. | Wise RA et al. | โ | 2020 | โ |
| Personality disorders and social support in cannabis dependence: A comparison with alcohol dependence. | Cougle JR et al. | โ | 2020 | โ |
| Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. | Bahji A et al. | โ | 2020 | โ |
| Trends in Cannabis Treatment Admissions in Adolescents/Young Adults: Analysis of TEDS-A 1992 to 2016. | Standeven LR et al. | โ | 2020 | โ |
| Update on the Neuropsychiatry of Substance Use Disorders. | Kolodner G et al. | โ | 2020 | โ |
| An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. | Budney AJ et al. | โ | 2019 | โ |
| Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted Infections/Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex With Men. | Gorbach PM et al. | โ | 2019 | โ |
| Correlates and Potential Confounds of Cannabis Withdrawal Among High-Risk Adolescents. | Ellingson JM et al. | โ | 2019 | โ |
| Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. | Lerner A et al. | โ | 2019 | โ |
| DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. | Livne O et al. | โ | 2019 | โ |
| Explorer les choix de cannabinoรฏdes pour la douleur neuropathique chronique chez les adultes plus รขgรฉs: Embรปches et faits saillants. | Kamrul R et al. | โ | 2019 | โ |
| Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights. | Kamrul R et al. | โ | 2019 | โ |
| Pharmacotherapies for cannabis dependence. | Nielsen S et al. | โ | 2019 | โ |
| Relationships between marijuana use, severity of marijuana-related problems, and health-related quality of life. | Liao JY et al. | โ | 2019 | โ |
| A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms. | Werneck MA et al. | โ | 2018 | โ |
| Cannabinoid disruption of learning mechanisms involved in reward processing. | Lupica CR et al. | โ | 2018 | โ |
| Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. | Rabin RA et al. | โ | 2018 | โ |
| Cognitive and Mental Health Predictors of Withdrawal Severity During an Active Attempt to Cut Down Cannabis Use. | Cousijn J et al. | โ | 2018 | โ |
| Considerations for clinical trials to study cannabinoids in Canadian children with neurologic disorders. | Kelly LE et al. | โ | 2018 | โ |
| Emerging Evidence for Cannabis' Role in Opioid Use Disorder. | Wiese B et al. | โ | 2018 | โ |
| Heavy marijuana use but not deprivation is associated with increased stressor reactivity. | Hefner KR et al. | โ | 2018 | โ |
| Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population. | Kelly JF et al. | โ | 2018 | โ |
| Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure. | Panlilio LV et al. | โ | 2018 | โ |
| The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. | Schlienz NJ et al. | โ | 2018 | โ |
| Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids. | Cousijn J et al. | โ | 2018 | โ |
| US Epidemiology of Cannabis Use and Associated Problems. | Hasin DS | โ | 2018 | โ |
| Building smart cannabis policy from the science up. | Weiss SRB et al. | โ | 2017 | โ |
| Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? | Perucca E | โ | 2017 | โ |
| Cannabis, alcohol use, psychological distress, and decision-making style. | Phillips JG et al. | โ | 2017 | โ |
| Cannabis and Canada's children and youth. | Grant CN et al. | โ | 2017 | โ |
| Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences. | Schlienz NJ et al. | โ | 2017 | โ |
| Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach. | Niaz K et al. | โ | 2017 | โ |
| Identifying HIV care enrollees at-risk for cannabis use disorder. | Hartzler B et al. | โ | 2017 | โ |
| Medical cannabis: Another piece in the mosaic of autoimmunity? | Katz D et al. | โ | 2017 | โ |
| The cannabis withdrawal syndrome: current insights. | Bonnet U et al. | โ | 2017 | โ |
| Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation. | Wesley MJ et al. | โ | 2016 | โ |
| Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. | Lawn W et al. | โ | 2016 | โ |
| Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases. | Fitzcharles MA et al. | โ | 2016 | โ |
| Cannabis withdrawal and sleep: A systematic review of human studies. | Gates P et al. | โ | 2016 | โ |
| Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study. | Davis JP et al. | โ | 2016 | โ |
| Correlates of Amount Spent on Marijuana Buds During a Discrete Purchase at Medical Marijuana Dispensaries: Results from a Pilot Study. | Kepple NJ et al. | โ | 2016 | โ |
| Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction. | Kutlu MG et al. | โ | 2016 | โ |
| Is the medical use of cannabis a therapeutic option for children? | Rieder MJ et al. | โ | 2016 | โ |
| Molecular Mechanisms of Cannabis Signaling in the Brain. | Ronan PJ et al. | โ | 2016 | โ |
| Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review. | Freynhagen R et al. | โ | 2016 | โ |
| Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. | Copeland J et al. | โ | 2016 | โ |
| Shifting the Paradigm: Adolescent Cannabis Abuse and the Need for Early Intervention. | Golick J | โ | 2016 | โ |
| The Formation of Marijuana Risk Perception in a Population of Substance Abusing Patients. | Wilkinson ST et al. | โ | 2016 | โ |
| Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum. | Tournier BB et al. | โ | 2016 | โ |
| Treatment of Cannabis Use Disorder: Current Science and Future Outlook. | Sherman BJ et al. | โ | 2016 | โ |
| Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review. | Beech RA et al. | โ | 2015 | โ |
| Cannabinoids and Epilepsy. | Rosenberg EC et al. | โ | 2015 | โ |
| Cannabis and psychopathology: The meandering journey of the last decade. | Ghosh A et al. | โ | 2015 | โ |
| Cannabis use and violence in three remote Aboriginal Australian communities: Analysis of clinic presentations. | Kylie Lee KS et al. | โ | 2015 | โ |
| Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race. | Soenksen S et al. | โ | 2015 | โ |
| Citicoline Treatment Improves Measures of Impulsivity and Task Performance in Chronic Marijuana Smokers: A Pilot BOLD fMRI Study. | Gruber SA et al. | โ | 2015 | โ |
| Medical use of cannabis: an addiction medicine perspective. | Cook J et al. | โ | 2015 | โ |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | โ | 2015 | โ |
| Risks associated with the non-medicinal use of cannabis. | Hoch E et al. | โ | 2015 | โ |
| The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence. | Allsop DJ et al. | โ | 2015 | โ |
| The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document. | Wilsey B et al. | โ | 2015 | โ |
| What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? | Hall W | โ | 2015 | โ |
| Association of dopamine receptor D2 TaqI A polymorphism and cannabis use disorder in Lagos, Nigeria. | Adedeji OH et al. | โ | 2014 | โ |
| Baclofen in the management of cannabis dependence syndrome. | Imbert B et al. | โ | 2014 | โ |
| Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future. | Panagis G et al. | โ | 2014 | โ |
| Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating. | Chesney T et al. | โ | 2014 | โ |
| Curious cases: Altered dose-response relationships in addiction genetics. | Uhl GR et al. | โ | 2014 | โ |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | โ | 2014 | โ |
| Have the genetics of cannabis involvement gone to pot? | Agrawal A et al. | โ | 2014 | โ |
| Pharmacotherapies for cannabis dependence. | Marshall K et al. | โ | 2014 | โ |
| Problems with the medicalization of marijuana. | Wilkinson ST et al. | โ | 2014 | โ |
| Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. | Yadav V et al. | โ | 2014 | โ |
| Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? | Oleson EB et al. | โ | 2014 | โ |
| The adverse health effects of chronic cannabis use. | Hall W et al. | โ | 2014 | โ |
| The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward. | Flores ร et al. | โ | 2014 | โ |
| Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study. | Weinstein AM et al. | โ | 2014 | โ |
| A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. | Verweij KJ et al. | โ | 2013 | โ |
| Altered resting-state connectivity in adolescent cannabis users. | Orr C et al. | โ | 2013 | โ |
| An exploratory study of cannabis withdrawal among Indigenous Australian prison inmates: study protocol. | Rogerson B et al. | โ | 2013 | โ |
| Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. | Crippa JA et al. | โ | 2013 | โ |
| Cannabis use in a Swiss male prison: qualitative study exploring detainees' and staffs' perspectives. | Ritter C et al. | โ | 2013 | โ |
| Cannabis withdrawal in chronic cannabis users with schizophrenia. | Boggs DL et al. | โ | 2013 | โ |
| DSM-5 criteria for substance use disorders: recommendations and rationale. | Hasin DS et al. | โ | 2013 | โ |
| Marijuana: current concepts(โ ). | Greydanus DE et al. | โ | 2013 | โ |
| Marijuana withdrawal and aggression among a representative sample of U.S. marijuana users. | Smith PH et al. | โ | 2013 | โ |
| Medical and recreational marijuana: commentary and review of the literature. | Wilkinson ST | โ | 2013 | โ |
| Molecular mechanisms of cannabinoid addiction. | Fratta W et al. | โ | 2013 | โ |
| Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice. | Aracil-Fernรกndez A et al. | โ | 2013 | โ |
| Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. | Koola MM et al. | โ | 2013 | โ |
| Suspected dronabinol withdrawal in an elderly cannabis-naive medically ill patient. | Muramatsu RS et al. | โ | 2013 | โ |
| Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers. | Hesse M et al. | โ | 2013 | โ |
| A brain on cannabinoids: the role of dopamine release in reward seeking. | Oleson EB et al. | โ | 2012 | โ |
| An Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology. | Lynskey MT et al. | โ | 2012 | โ |
| A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativexยฎ (nabiximols). | Notcutt W et al. | โ | 2012 | โ |
| Characteristics of clinically anxious versus non-anxious regular, heavy marijuana users. | Van Dam NT et al. | โ | 2012 | โ |
| Chemistry, metabolism, and toxicology of cannabis: clinical implications. | Sharma P et al. | โ | 2012 | โ |
| Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. | Peters EN et al. | โ | 2012 | โ |
| Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. | Chimalakonda KC et al. | โ | 2012 | โ |
| Diagnostic criteria for cannabis withdrawal syndrome. | Gorelick DA et al. | โ | 2012 | โ |
| Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. | Brents LK et al. | โ | 2012 | โ |
| Quantifying the clinical significance of cannabis withdrawal. | Allsop DJ et al. | โ | 2012 | โ |
| Seizure exacerbation in two patients with focal epilepsy following marijuana cessation. | Hegde M et al. | โ | 2012 | โ |
| State of the art treatments for cannabis dependence. | Danovitch I et al. | โ | 2012 | โ |
| The co-occurring use and misuse of cannabis and tobacco: a review. | Agrawal A et al. | โ | 2012 | โ |
| Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. | Harte-Hargrove LC et al. | โ | 2012 | โ |
| Altered Mesolimbic Dopamine System in THC Dependence. | Spiga S et al. | โ | 2011 | โ |
| Beyond THC: The New Generation of Cannabinoid Designer Drugs. | Fattore L et al. | โ | 2011 | โ |
| Cannabis in sport: anti-doping perspective. | Huestis MA et al. | โ | 2011 | โ |
| Does marijuana use lead to aggression and violent behavior? | Ostrowsky MK | โ | 2011 | โ |
| Increased blood pressure after abrupt cessation of daily cannabis use. | Vandrey R et al. | โ | 2011 | โ |
| Marijuana dependence: not just smoke and mirrors. | Ramesh D et al. | โ | 2011 | โ |
| Neurochemical basis of cannabis addiction. | Maldonado R et al. | โ | 2011 | โ |
| Pharmacological treatment of cannabis dependence. | Weinstein AM et al. | โ | 2011 | โ |
| Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. | Wesley MJ et al. | โ | 2011 | โ |
| Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability. | Beckley EH et al. | โ | 2011 | โ |
| The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. | Allsop DJ et al. | โ | 2011 | โ |
| The safety of modafinil in combination with oral โ9-tetrahydrocannabinol in humans. | Sugarman DE et al. | โ | 2011 | โ |
| Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence. | Spiga S et al. | โ | 2010 | โ |
| Baclofen in cannabis dependence syndrome. | Nanjayya SB et al. | โ | 2010 | โ |
| Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. | Preuss UW et al. | โ | 2010 | โ |
| Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. | Levin KH et al. | โ | 2010 | โ |
| FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. | Falenski KW et al. | โ | 2010 | โ |
| Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. | Ehlers CL et al. | โ | 2010 | โ |
| New horizons for therapeutics in drug and alcohol abuse. | Jupp B et al. | โ | 2010 | โ |
| [Pharmacological and psychosocial interventions for cannabis use disorders]. | Budney AJ et al. | โ | 2010 | โ |
| Adverse health effects of non-medical cannabis use. | Hall W et al. | โ | 2009 | โ |
| A placebo-controlled trial of buspirone for the treatment of marijuana dependence. | McRae-Clark AL et al. | โ | 2009 | โ |
| A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. | Carpenter KM et al. | โ | 2009 | โ |
| Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review. | Wilson N et al. | โ | 2009 | โ |
| [Cyclical hyperemesis secondary to cannabis abuse]. | Ochoa-Mangado E et al. | โ | 2009 | โ |
| Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. | Winstock AR et al. | โ | 2009 | โ |
| Sex differences in the self-administration of cannabinoids and other drugs of abuse. | Fattore L et al. | โ | 2009 | โ |
| The adverse health effects of cannabis use: what are they, and what are their implications for policy? | Hall W | โ | 2009 | โ |
| Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. | Schneider M et al. | โ | 2008 | โ |
| A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. | Vandrey RG et al. | โ | 2008 | โ |
| Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. | Chung T et al. | โ | 2008 | โ |
| Chronic stress, drug use, and vulnerability to addiction. | Sinha R | โ | 2008 | โ |
| Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? | Agrawal A et al. | โ | 2008 | โ |
| Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. | Schneider M | โ | 2008 | โ |
| The endocannabinoid system: emotion, learning and addiction. | Moreira FA et al. | โ | 2008 | โ |
| Withdrawal-like behavior in planarians is dependent on drug exposure duration. | Sacavage S et al. | โ | 2008 | โ |
| Cannabis and psychosis: an update on course and biological plausible mechanisms. | Linszen D et al. | โ | 2007 | โ |
| Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the national epidemiological survey on alcohol and related conditions. | Agrawal A et al. | โ | 2007 | โ |
| Marijuana dependence and its treatment. | Budney AJ et al. | โ | 2007 | โ |
| Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. | Budney AJ et al. | โ | 2007 | โ |
| Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). | Pierucci-Lagha A et al. | โ | 2007 | โ |
| The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. | Coulston CM et al. | โ | 2007 | โ |
| The role of stress in addiction relapse. | Sinha R | โ | 2007 | โ |